For example, KRAS mutations are found in about 40% of colorectal cancer cases and directly affect the RAS-MAPK signaling pathway, which is responsible for controlling cell growth and division (Ahmad et al., 2021; Vitiello et al., 2019). This evidence concerns the gene KRAS and colorectal cancer.